Semaphorin3A, Neuropilin-1, and PlexinA1 are required for lymphatic valve formation.
about
NRP1 function and targeting in neurovascular development and eye diseaseVascularisation of the central nervous systemLymphangiogenesis and metastasis--a closer look at the neuropilin/semaphorin3 axisDevelopment of the mammalian lymphatic vasculatureLymph flow regulates collecting lymphatic vessel maturation in vivo.Primary and secondary lymphatic valve development: molecular, functional and mechanical insights.Nerve growth factor regulates neurolymphatic remodeling during corneal inflammation and resolution.Temporal and spatial regulation of epsin abundance and VEGFR3 signaling are required for lymphatic valve formation and functionVenous endothelial injury in central nervous system diseasesTie1 is required for lymphatic valve and collecting vessel development.EphB4 forward signalling regulates lymphatic valve development.GATA2 is required for lymphatic vessel valve development and maintenance.Class 3 semaphorins negatively regulate dermal lymphatic network formation.Foxc1 and Foxc2 deletion causes abnormal lymphangiogenesis and correlates with ERK hyperactivationBone morphogenetic protein 9 (BMP9) controls lymphatic vessel maturation and valve formationDendritic cell interactions with lymphatic endothelium.Class 3 semaphorins in cardiovascular development.Human airway smooth muscle cell proliferation from asthmatics is negatively regulated by semaphorin3A.Significance of semaphorin-3A and MMP-14 protein expression in non-small cell lung cancer.Flow control in our vessels: vascular valves make sure there is no way back.Neurovascular development and links to disease.Navigation rules for vessels and neurons: cooperative signaling between VEGF and neural guidance cues.Mechanical forces in lymphatic vascular development and disease.Lymphangiogenic factors, mechanisms, and applications.Flow-regulated lymphatic vasculature development and signaling.Morphogenesis of the lymphatic vasculature: A focus on new progenitors and cellular mechanisms important for constructing lymphatic vessels.The lymphatic system and pancreatic cancer.Semaphorins and their Signaling Mechanisms.The lymphatic vasculature: development and role in shaping immunity.Lymphatic pumping: mechanics, mechanisms and malfunction.The role of the semaphorins in cancer.Intestinal lymphatic vasculature: structure, mechanisms and functions.Altered proliferative ability of neuronal progenitors in PlexinA1 mutant mice.Molecular controls of lymphatic VEGFR3 signaling.Smooth muscle cell recruitment to lymphatic vessels requires PDGFB and impacts vessel size but not identity.Intraluminal valves: development, function and disease.Human venous valve disease caused by mutations in FOXC2 and GJC2.Cdk5 controls lymphatic vessel development and function by phosphorylation of Foxc2.Defective lymphatic valve development and chylothorax in mice with a lymphatic-specific deletion of Connexin43.Quantum dot multiplexing for the profiling of cellular receptors.
P2860
Q26765952-7BB2A4A9-7C5D-47B1-B1AE-B659AF2FDFB8Q26801786-C48BB989-5ED5-450E-8BFD-8349B75475CDQ26825144-45659B9E-ED6A-46D9-BA6A-FBB76D5A638DQ26852649-46ACEC2E-2656-4C10-B83C-682E2F9594EBQ27332557-E928C004-F965-4FCF-94CE-5E840D51B43AQ34432002-0DD56003-D038-43F5-A3BA-89DA48CD3B5BQ34483220-25B3885A-F142-4DED-B3F5-69E0B2DE9E6AQ34483937-A9432A60-27C9-4CED-BE65-2C387AB54AD4Q35042424-FF020F6B-4525-4B7D-8CDF-3B39A1DA1DF0Q35218933-C09ED0B3-97B6-484B-9243-0CFE57DB9056Q35486972-C495E14D-0BF8-4A3C-989B-B3072F40C840Q36040456-A43BEAD4-0F54-4BA3-A0D9-57947433C666Q36090884-9E0E99F0-1CF9-44A6-92BA-17D8950C5029Q37042262-6037BF7B-66A7-4C36-AD7A-4DFDA0845957Q37047011-CFA5D619-C32D-45D2-BE88-1CA87F49CA4BQ37190294-C74E621E-FC3C-412F-B5B7-EC0873C3C3BBQ37509074-CCDBDD38-A601-4837-B55A-CEFB70E01669Q37696987-69F0CC3E-2B85-49BD-ABA3-D59751370790Q37720001-13192BA3-6B82-4AC8-8450-CCA47BD4441AQ38038075-775D2FD9-17F8-4869-9BB6-CCE9195CAA01Q38087874-0206C6F8-68E3-4F63-83D9-D71395EC8EA9Q38087875-9A4B7771-DC46-4C13-B85E-A6A070865532Q38105904-FF58F909-E36A-4B2C-BC16-1F4148CE4285Q38192927-8F45B9E8-4824-4F51-A28B-083CA53E1446Q38233041-D8BB7F0C-F405-4B40-B744-B5EF3B54DB78Q38558116-83DA2F69-9EB3-4FA1-92A3-CFD3AE85F2D0Q38689578-273BEB09-B734-4315-9A18-5BEC261DB5FEQ38804261-C087B229-F3EF-40AF-9758-AAED00B8D2C8Q38810930-1C3A065C-8B19-4129-8042-689869FDFC6EQ38843093-B023ED5B-0D39-4259-9613-ED51AD7BCD9AQ38929961-C8C53F13-2F70-4D69-AE2C-6CE8040C895CQ39401415-36F51FC9-AB3A-46C9-82C8-2A3C7F1E7F9EQ40938701-83ABC267-A454-4900-901B-B036352F6522Q42094869-9867CEF2-1FA3-4B4C-B97C-93BC11AB2EBDQ46812143-A7C20348-1CD8-4CD1-B722-B25A82268C56Q47105284-B4C35047-AC4A-4F0E-9B6F-3B435550C537Q48099591-D14775C2-C7C2-4362-AE52-3B52E687D7E6Q48181375-BF3A01F2-B8C0-4798-ADED-7CFAEF99B79EQ49419096-FA5E5FB0-0430-43C1-B7CF-274D0CFC19D6Q51717661-29B5AC62-4328-4B63-BE91-C65C5EB1880C
P2860
Semaphorin3A, Neuropilin-1, and PlexinA1 are required for lymphatic valve formation.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Semaphorin3A, Neuropilin-1, and PlexinA1 are required for lymphatic valve formation.
@en
Semaphorin3A, Neuropilin-1, and PlexinA1 are required for lymphatic valve formation.
@nl
type
label
Semaphorin3A, Neuropilin-1, and PlexinA1 are required for lymphatic valve formation.
@en
Semaphorin3A, Neuropilin-1, and PlexinA1 are required for lymphatic valve formation.
@nl
prefLabel
Semaphorin3A, Neuropilin-1, and PlexinA1 are required for lymphatic valve formation.
@en
Semaphorin3A, Neuropilin-1, and PlexinA1 are required for lymphatic valve formation.
@nl
P2093
P2860
P50
P1433
P1476
Semaphorin3A, Neuropilin-1, and PlexinA1 are required for lymphatic valve formation.
@en
P2093
Anne Eichmann
Brunella Cristofaro
Charlotte H Maden
Claudia Prahst
Isabelle Brunet
Jean Léon Thomas
Jihane Soueid
Karine Bouvrée
Marie-Stéphane Aigrot
Nayoki Miura
P2860
P304
P356
10.1161/CIRCRESAHA.112.269316
P577
2012-06-21T00:00:00Z